Clinical Research Directory

Inclusion Criteria: * Age \> 18 years; * Patients with a LVEF≤35% assessed at least after a 40 to 90 days period (depending on the presence of coronary revascularization) following an index myocardial infarction; * Left ventricular systolic impairment as defined by LVEF≤35% by any current standard technique (echocardiogram, multiple gated acquisition scan, or MRI) within 2 months; * Able and willing to comply with all pre-, post- and follow-up testing, and requirements; * Use of maximum tolerated doses of ACE inhibitors (or Angiotensin II Receptor Blockers if intolerant of ACE) and Beta Blockers and MRA as per ESC guidelines; * Person affiliated to or beneficiary of a social security plan * Person informed about study organization and having signed the informed consent Exclusion Criteria: * History of cardiac arrest or sustained VT or VF unless within 48 hours of an acute myocardial infarction; * Standard contraindications for cardiac LGE-MRI; * Hypersensitivity to gadolinium-based contrast agent; * Currently implanted permanent pacemaker and/or ICD; * Patient refusal of ICD/ILR implantation; * Currently implanted permanent pacemaker and/or ICD; * Clinical indication for or Cardiac Resynchronization Therapy (CRT); * Severe renal insufficiency defined by a glomerular filtration rate (GFR) \< 30 mL/min/1.73m²; * Recent PTCA (within 30 days) or CABG (within 90 days); * Baseline NYHA functional class IV; * Contraindication for ICD implantation according to current guidelines; * Woman of childbearing age without effective contraception; * Person referred in articles L.1121-5, L. 1121-7 and L.1121-8 of the French Public Health Code.